'Now is not the time to retreat': BMS CEO blasts Trump admin tariffs, health reforms amid $40B US investment pledge
Bristol Myers Squibb plans to invest $40 billion across U.S. R&D, technology and manufacturing over the next five years, CEO Chris Boerner said in an op-ed published by Stat this week.
Bristol Myers Squibb plans to invest $40 billion across U.S. R&D, technology and manufacturing over the next five years, CEO Chris Boerner said in an op-ed published by Stat this week.
